Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

SeaStar Medical Holding (ICUCW) Cash from Operations (2023 - 2025)

SeaStar Medical Holding's Cash from Operations history spans 3 years, with the latest figure at 4094000.0 for Q4 2025.

  • For Q4 2025, Cash from Operations rose 12.76% year-over-year to 4094000.0; the TTM value through Dec 2025 reached 13599000.0, up 15.04%, while the annual FY2025 figure was 13599000.0, 15.04% up from the prior year.
  • Cash from Operations reached 4094000.0 in Q4 2025 per ICUCW's latest filing, down from 3844000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 1337000.0 in Q3 2023 to a low of 5002000.0 in Q3 2024.
  • Average Cash from Operations over 3 years is 3324250.0, with a median of 3247500.0 recorded in 2024.
  • Peak YoY movement for Cash from Operations: crashed 274.12% in 2024, then grew 23.91% in 2025.
  • A 3-year view of Cash from Operations shows it stood at 4485000.0 in 2023, then decreased by 4.64% to 4693000.0 in 2024, then rose by 12.76% to 4094000.0 in 2025.
  • Per Business Quant, the three most recent readings for ICUCW's Cash from Operations are 4094000.0 (Q4 2025), 3844000.0 (Q3 2025), and 3007000.0 (Q2 2025).